CareRx Corporation

Equities

CRRX

CA14173C1059

Drug Retailers

Market Closed - Toronto S.E. 03:57:47 2024-04-18 pm EDT 5-day change 1st Jan Change
2.2 CAD +1.85% Intraday chart for CareRx Corporation +7.32% +36.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CareRx Down 3% as Notes Ontario Government's Pause of Planned Fee Changes MT
CareRx Brief: Notes Ontario Government's Pause of Planned Fee Changes MT
CareRx Brief: In connection with Prior announced normal course issuer bid to Buy Up To 1 Million of its common shares, it has entered into an automatic share purchase plan MT
CareRx Narrows Q4 Loss, Revenue Falls MT
Transcript : CareRx Corporation, Q4 2023 Earnings Call, Mar 07, 2024
CareRx Brief: Revenue for Q4 $91.1 million; Net loss for the quarter was $3.7 million MT
CareRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CareRx Corporation Reports Goodwill and Intangible Assets Impairment Charges for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Powell Still in -2- DJ
North American Morning Briefing : Powell Still in the Spotlight; ECB Rate Decision Looms DJ
CareRx Corporation Announces Closing of $70 Million Debt Refinancing CI
CareRx Completes C$70-Million Debt Refinancing MT
CareRx Brief: Says Closed $70 Million Debt Refinancing MT
CareRx Announced $70 million Debt Refinancing MT
CareRx Brief: Announcing $70 million Debt Refinancing MT
CareRx Corporation Announces $70 Million Debt Refinancing CI
Transcript : CareRx Corporation, Q3 2023 Earnings Call, Nov 08, 2023
Tranche Update on CareRx Corporation's Equity Buyback Plan announced on August 28, 2023. CI
CareRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
North American Morning Briefing : Stock Futures -2- DJ
CareRx Says Received Regulatory Approval for Launch of its Normal Course Issuer Bid MT
CareRx Brief: Says Received Regulatory Approval for Launch of its Normal Course Issuer Bid MT
CareRx Plans to Buy Back Shares Through a Normal-Course Issuer Bid MT
CareRx Corporation announces an Equity Buyback for 1,000,000 shares, representing 1.73% of its issued share capital. CI
CareRx Corporation authorizes a Buyback Plan. CI
Chart CareRx Corporation
More charts
CareRx Corporation is a Canada-based provider of pharmacy services to seniors living communities. The Company serves over 94,000 residents in over 1,500 senior and other congregate care communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. It supports its home care partners by providing solutions for the supply of chronic medication. It offers a range of medication solutions. Its technology automates the preparation and verification of multi-dose compliance packaging of medication, providing the safety and adherence for individuals with complex medication regimes. Its network of pharmacy fulfillment centers delivers solutions for the supply of chronic medication and other specialty clinical pharmacy services. The Company provides services in rural and urban areas throughout Ontario, Alberta, British Columbia, and parts of Saskatchewan. It works with home operator partners to promote resident health, staff education and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.2 CAD
Average target price
3.625 CAD
Spread / Average Target
+64.77%
Consensus
  1. Stock Market
  2. Equities
  3. CRRX Stock
  4. News CareRx Corporation
  5. CareRx : Closes Equity Financings of Subscription Receipts for $63.3 Million in Proceeds